{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:07:06Z","timestamp":1788502026912,"version":"build-2803163510"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Northern Ireland Kidney Research Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s40620-018-0549-4","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T10:58:26Z","timestamp":1541588306000},"page":"389-399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Cardiovascular risk in renal transplant recipients"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7140-000X","authenticated-orcid":false,"given":"Paul A.","family":"Devine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling E.","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6110-7253","authenticated-orcid":false,"given":"Alexander P.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"issue":"23","key":"549_CR1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/nejm199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe RA, Ashby VB, Milford EL et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341(23):1725\u20131730. https:\/\/doi.org\/10.1056\/nejm199912023412303","journal-title":"N Engl J Med"},{"issue":"1","key":"549_CR2","first-page":"37","volume":"37","author":"K Landreneau","year":"2010","unstructured":"Landreneau K, Lee K, Landreneau MD (2010) Quality of life in patients undergoing hemodialysis and renal transplantation\u2013a meta-analytic review. Nephrol Nurs J 37(1):37\u201344","journal-title":"Nephrol Nurs J"},{"issue":"2","key":"549_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/ckj\/sfw135","volume":"10","author":"M Pippias","year":"2017","unstructured":"Pippias M, Kramer A, Noordzij M et al (2017) The European Renal Association\u2014European Dialysis and Transplant Association Registry Annual Report 2014: a summary. Clin Kidney J 10(2):154\u2013169. https:\/\/doi.org\/10.1093\/ckj\/sfw135","journal-title":"Clin Kidney J"},{"issue":"9224","key":"549_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0140-6736(00)02456-9","volume":"356","author":"C Baigent","year":"2000","unstructured":"Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356(9224):147\u2013152. https:\/\/doi.org\/10.1016\/s0140-6736(00)02456-9","journal-title":"Lancet"},{"issue":"Suppl 3","key":"549_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transpl 9(Suppl 3):S1\u2013S155. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02834.x","journal-title":"Am J Transpl"},{"issue":"Suppl. 1","key":"549_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000481367","volume":"137","author":"S Methven","year":"2017","unstructured":"Methven S, Steenkamp R, Fraser S (2017) UK Renal Registry 19th Annual Report: Chap. 5 survival and causes of death in UK adult patients on renal replacement therapy in 2015: National and Centre-specific Analyses. Nephron 137(Suppl. 1):117\u2013150. https:\/\/doi.org\/10.1159\/000481367","journal-title":"Nephron"},{"issue":"3","key":"549_CR7","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2018.01.002","volume":"71","author":"R Saran","year":"2018","unstructured":"Saran R, Robinson B, Abbott KC et al (2018) US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis 71(3):A7. https:\/\/doi.org\/10.1053\/j.ajkd.2018.01.002","journal-title":"Am J Kidney Dis"},{"key":"549_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy168","author":"H Burton","year":"2018","unstructured":"Burton H, Iyamu Perisanidou L, Steenkamp R et al (2018) Causes of renal allograft failure in the UK: trends in UK Renal Registry and National Health Service Blood and Transplant data from 2000 to 2013. Nephrol Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfy168","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"549_CR9","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(5):S112\u2013S119. https:\/\/doi.org\/10.1053\/ajkd.1998.v32.pm9820470","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"549_CR10","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.V1071606","volume":"10","author":"PS Parfrey","year":"1999","unstructured":"Parfrey PS, Foley RN (1999) The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10(7):1606\u20131615","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"549_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1681\/ASN.2004070580","volume":"16","author":"KL Lentine","year":"2005","unstructured":"Lentine KL, Brennan DC, Schnitzler MA (2005) Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 16(2):496\u2013506. https:\/\/doi.org\/10.1681\/ASN.2004070580","journal-title":"J Am Soc Nephrol"},{"issue":"9374","key":"549_CR12","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/s0140-6736(03)13638-0","volume":"361","author":"H Holdaas","year":"2003","unstructured":"Holdaas H, Fellstr\u00f6m B, Jardine AG et al (2003) Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361(9374):2024\u20132031. https:\/\/doi.org\/10.1016\/s0140-6736(03)13638-0","journal-title":"Lancet"},{"issue":"4 Pt 2","key":"549_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2105\/AJPH.47.4_Pt_2.4","volume":"47","author":"TR Dawber","year":"1957","unstructured":"Dawber TR, Moore FE, Mann GV (1957) Coronary heart disease in the Framingham study. Am J Public Health Nations Health 47(4 Pt 2):4\u201324","journal-title":"Am J Public Health Nations Health"},{"issue":"5","key":"549_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0272-6386(98)70145-3","volume":"32","author":"AS Levey","year":"1998","unstructured":"Levey AS, Beto JA, Coronado BE et al (1998) Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32(5):853\u2013906","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"549_CR15","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V1191735","volume":"11","author":"BL Kasiske","year":"2000","unstructured":"Kasiske BL, Chakkera HA, Roel J (2000) Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11(9):1735\u20131743","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"549_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1432-2277.2011.01242.x","volume":"24","author":"C Ponticelli","year":"2011","unstructured":"Ponticelli C, Cucchiari D, Graziani G (2011) Hypertension in kidney transplant recipients. Transpl Int 24(6):523\u2013533. https:\/\/doi.org\/10.1111\/j.1432-2277.2011.01242.x","journal-title":"Transpl Int"},{"issue":"8","key":"549_CR17","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1681\/ASN.V48s30","volume":"4","author":"MR First","year":"1994","unstructured":"First MR, Neylan JF, Rocher LL, Tejani A (1994) Hypertension after renal transplantation. J Am Soc Nephrol 4(8):S30\u2013S36","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"549_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.ajkd.2004.03.013","volume":"43","author":"BL Kasiske","year":"2004","unstructured":"Kasiske BL, Anjum S, Shah R et al (2004) Hypertension after kidney transplantation. Am J Kidney Dis 43(6):1071\u20131081","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"549_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/ndt\/14.3.648","volume":"14","author":"S Aakhus","year":"1999","unstructured":"Aakhus S, Dahl K, Wider\u00f8e TE (1999) Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transpl 14(3):648\u2013654. https:\/\/doi.org\/10.1093\/ndt\/14.3.648","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"549_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/hjh.0000000000001530","volume":"36","author":"F Mallamaci","year":"2018","unstructured":"Mallamaci F, D\u2019Arrigo G, Tripepi R et al (2018) Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients. J Hypertens 36(1):119\u2013125. https:\/\/doi.org\/10.1097\/hjh.0000000000001530","journal-title":"J Hypertens"},{"issue":"12","key":"549_CR21","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/ndt\/gfx283","volume":"32","author":"JM Halimi","year":"2017","unstructured":"Halimi JM, Persu A, Sarafidis PA et al (2017) Optimizing hypertension management in renal transplantation: a call to action. Nephrol Dial Transpl 32(12):1959\u20131962. https:\/\/doi.org\/10.1093\/ndt\/gfx283","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"549_CR22","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1111\/j.1600-6143.2005.01093.x","volume":"5","author":"G Opelz","year":"2005","unstructured":"Opelz G, Dohler B (2005) Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transpl 5(11):2725\u20132731. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01093.x","journal-title":"Am J Transpl"},{"issue":"1","key":"549_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","volume":"53","author":"G Opelz","year":"1998","unstructured":"Opelz G, Wujciak T, Ritz E, for the Collaborative Transplant S (1998) Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 53(1):217\u2013222. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00744.x","journal-title":"Kidney Int"},{"issue":"4","key":"549_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ki.2009.377","volume":"77","author":"BL Kasiske","year":"2010","unstructured":"Kasiske BL, Zeier MG, Chapman JR et al (2010) KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 77(4):299\u2013311. https:\/\/doi.org\/10.1038\/ki.2009.377","journal-title":"Kidney Int"},{"issue":"1","key":"549_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12882-017-0553-2","volume":"18","author":"RJ Baker","year":"2017","unstructured":"Baker RJ, Mark PB, Patel RK et al (2017) Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol 18(1):174. https:\/\/doi.org\/10.1186\/s12882-017-0553-2","journal-title":"BMC Nephrol"},{"issue":"2","key":"549_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40620-017-0378-x","volume":"30","author":"C Ponticelli","year":"2017","unstructured":"Ponticelli C, Cucchiari D (2017) Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment. J Nephrol 30(2):155\u2013157. https:\/\/doi.org\/10.1007\/s40620-017-0378-x","journal-title":"J Nephrol"},{"issue":"1","key":"549_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/ckj\/sfx149","volume":"11","author":"A Kramer","year":"2018","unstructured":"Kramer A, Pippias M, Noordzij M et al (2018) The European Renal Association\u2013European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary. Clin Kidney J 11(1):108\u2013122. https:\/\/doi.org\/10.1093\/ckj\/sfx149","journal-title":"Clin Kidney J"},{"issue":"1","key":"549_CR28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","volume":"7","author":"BL Kasiske","year":"1996","unstructured":"Kasiske BL, Guijarro C, Massy ZA et al (1996) Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7(1):158\u2013165","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"549_CR29","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/01.TP.0000164147.60036.67","volume":"79","author":"V Ramanathan","year":"2005","unstructured":"Ramanathan V, Goral S, Tanriover B et al (2005) Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation 79(10):1453\u20131458","journal-title":"Transplantation"},{"issue":"6","key":"549_CR30","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1111\/j.1523-1755.2005.00349.x","volume":"67","author":"FG Cosio","year":"2005","unstructured":"Cosio FG, Kudva Y, van der Velde M et al (2005) New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 67(6):2415\u20132421. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00349.x","journal-title":"Kidney Int"},{"issue":"12 suppl 3","key":"549_CR31","doi-asserted-by":"publisher","first-page":"S291","DOI":"10.1681\/asn.2006080929","volume":"17","author":"E Rodrigo","year":"2006","unstructured":"Rodrigo E, Fern\u00e1ndez-Fresnedo G, Valero R et al (2006) New-onset diabetes after kidney transplantation: risk factors. J Am Soc Nephrol 17(12 suppl 3):S291\u2013S295. https:\/\/doi.org\/10.1681\/asn.2006080929","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"549_CR32","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1111\/ajt.12850","volume":"14","author":"A Sharif","year":"2014","unstructured":"Sharif A, Hecking M, de Vries AP et al (2014) Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transpl 14(9):1992\u20132000. https:\/\/doi.org\/10.1111\/ajt.12850","journal-title":"Am J Transpl"},{"issue":"1","key":"549_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.kint.2017.12.026","volume":"94","author":"U Panchapakesan","year":"2018","unstructured":"Panchapakesan U, Pollock C (2018) Drug repurposing in kidney disease. Kidney Int 94(1):40\u201348. https:\/\/doi.org\/10.1016\/j.kint.2017.12.026","journal-title":"Kidney Int"},{"issue":"s7","key":"549_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1600-6135.2004.0355.x","volume":"4","author":"B Kasiske","year":"2004","unstructured":"Kasiske B, Cosio FG, Beto J et al (2004) Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transpl 4(s7):13\u201353. https:\/\/doi.org\/10.1111\/j.1600-6135.2004.0355.x","journal-title":"Am J Transpl"},{"issue":"18","key":"549_CR35","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.2165\/00003495-200464180-00004","volume":"64","author":"JMM Boots","year":"2004","unstructured":"Boots JMM, Christiaans MHL, van Hooff JP (2004) Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk. Drugs 64(18):2047\u20132073. https:\/\/doi.org\/10.2165\/00003495-200464180-00004","journal-title":"Drugs"},{"issue":"9800","key":"549_CR36","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/s0140-6736(11)61334-2","volume":"378","author":"AG Jardine","year":"2011","unstructured":"Jardine AG, Gaston RS, Fellstrom BC, Holdaas H (2011) Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet 378(9800):1419\u20131427. https:\/\/doi.org\/10.1016\/s0140-6736(11)61334-2","journal-title":"Lancet"},{"issue":"5","key":"549_CR37","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/ndt\/gfh735","volume":"20","author":"H Holdaas","year":"2005","unstructured":"Holdaas H, Fellstrom B, Jardine AG et al (2005) Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation. Nephrol Dial Transpl 20(5):974\u2013980. https:\/\/doi.org\/10.1093\/ndt\/gfh735","journal-title":"Nephrol Dial Transpl"},{"key":"549_CR38","doi-asserted-by":"publisher","first-page":"i2609","DOI":"10.1136\/bmj.i2609","volume":"353","author":"S Mayor","year":"2016","unstructured":"Mayor S (2016) NICE recommends PCSK9 inhibitors for patients not responding to statins. BMJ 353:i2609. https:\/\/doi.org\/10.1136\/bmj.i2609","journal-title":"BMJ"},{"issue":"18","key":"549_CR39","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC et al (2017) Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 376(18):1713\u20131722. https:\/\/doi.org\/10.1056\/NEJMoa1615664","journal-title":"N Engl J Med"},{"issue":"4","key":"549_CR40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1681\/ASN.V114753","volume":"11","author":"BL Kasiske","year":"2000","unstructured":"Kasiske BL, Klinger D (2000) Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 11(4):753\u2013759","journal-title":"J Am Soc Nephrol"},{"key":"549_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/IJNRD.S161001","volume":"11","author":"LA Weinrauch","year":"2018","unstructured":"Weinrauch LA, Claggett B, Liu J et al (2018) Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial. Int J Nephrol Renovasc Dis 11:155\u2013164. https:\/\/doi.org\/10.2147\/IJNRD.S161001","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"6","key":"549_CR42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1159\/000345476","volume":"36","author":"KL Lentine","year":"2012","unstructured":"Lentine KL, Delos Santos R, Axelrod D et al (2012) Obesity and kidney transplant candidates: how big is too big for transplantation? Am J Nephrol 36(6):575\u2013586","journal-title":"Am J Nephrol"},{"issue":"2","key":"549_CR43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1523-1755.2003.00761.x","volume":"63","author":"CW Glanton","year":"2003","unstructured":"Glanton CW, Kao TC, Cruess D et al (2003) Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 63(2):647\u2013653. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00761.x","journal-title":"Kidney Int"},{"issue":"2","key":"549_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/tp.0000000000000028","volume":"98","author":"BB Nicoletto","year":"2014","unstructured":"Nicoletto BB, Fonseca NK, Manfro RC et al (2014) Effects of obesity on kidney transplantation outcomes: a systematic review and meta-analysis. Transplantation 98(2):167\u2013176. https:\/\/doi.org\/10.1097\/tp.0000000000000028","journal-title":"Transplantation"},{"issue":"2","key":"549_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/TP.0b013e31817ef0f9","volume":"86","author":"KL Lentine","year":"2008","unstructured":"Lentine KL, Rocca-Rey LA, Bacchi G et al (2008) Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review. Transplantation 86(2):303\u2013312. https:\/\/doi.org\/10.1097\/TP.0b013e31817ef0f9","journal-title":"Transplantation"},{"issue":"11","key":"549_CR46","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1111\/j.1600-6143.2005.01073.x","volume":"5","author":"KA Armstrong","year":"2005","unstructured":"Armstrong KA, Campbell SB, Hawley CM et al (2005) Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transpl 5(11):2710\u20132718. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01073.x","journal-title":"Am J Transpl"},{"issue":"4","key":"549_CR47","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/00007890-199310000-00008","volume":"56","author":"CP Johnson","year":"1993","unstructured":"Johnson CP, Gallagher-Lepak S, Zhu YR et al (1993) Factors influencing weight gain after renal transplantation. Transplantation 56(4):822\u2013827","journal-title":"Transplantation"},{"issue":"3","key":"549_CR48","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1399-0012.2008.00792.x","volume":"22","author":"EA Elster","year":"2008","unstructured":"Elster EA, Leeser DB, Morrissette C et al (2008) Obesity following kidney transplantation and steroid avoidance immunosuppression. Clin Transpl 22(3):354\u2013359. https:\/\/doi.org\/10.1111\/j.1399-0012.2008.00792.x","journal-title":"Clin Transpl"},{"issue":"9","key":"549_CR49","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/ajt.14258","volume":"17","author":"MC Foster","year":"2017","unstructured":"Foster MC, Weiner DE, Bostom AG et al (2017) Filtration markers, cardiovascular disease, mortality, and kidney outcomes in stable kidney transplant recipients: the FAVORIT Trial. Am J Transpl 17(9):2390\u20132399. https:\/\/doi.org\/10.1111\/ajt.14258","journal-title":"Am J Transpl"},{"issue":"9","key":"549_CR50","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1111\/j.1600-6143.2012.04101.x","volume":"12","author":"DE Weiner","year":"2012","unstructured":"Weiner DE, Carpenter MA, Levey AS et al (2012) Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial. Am J Transpl 12(9):2437\u20132445. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04101.x","journal-title":"Am J Transpl"},{"issue":"1","key":"549_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/tri.12217","volume":"27","author":"C Legendre","year":"2014","unstructured":"Legendre C, Canaud G, Martinez F (2014) Factors influencing long-term outcome after kidney transplantation. Transpl Int 27(1):19\u201327. https:\/\/doi.org\/10.1111\/tri.12217","journal-title":"Transpl Int"},{"issue":"7","key":"549_CR52","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2215\/CJN.01310211","volume":"6","author":"MK Shamseddin","year":"2011","unstructured":"Shamseddin MK, Knoll GA (2011) Posttransplantation proteinuria: an approach to diagnosis and management. Clin J Am Soc Nephrol 6(7):1786\u20131793. https:\/\/doi.org\/10.2215\/CJN.01310211","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"549_CR53","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/00007890-200204270-00028","volume":"73","author":"G Fernandez-Fresnedo","year":"2002","unstructured":"Fernandez-Fresnedo G, Escallada R, Rodrigo E et al (2002) The risk of cardiovascular disease associated with proteinuria in renal transplant patients. Transplantation 73(8):1345\u20131348","journal-title":"Transplantation"},{"issue":"10","key":"549_CR54","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","volume":"7","author":"S Hiremath","year":"2007","unstructured":"Hiremath S, Fergusson D, Doucette S et al (2007) Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transpl 7(10):2350\u20132360. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01928.x","journal-title":"Am J Transpl"},{"issue":"1","key":"549_CR55","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","volume":"69","author":"S Hiremath","year":"2017","unstructured":"Hiremath S, Fergusson DA, Fergusson N et al (2017) Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials. Am J Kidney Dis 69(1):78\u201386. https:\/\/doi.org\/10.1053\/j.ajkd.2016.08.018","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"549_CR56","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/01.tp.0000437672.78716.28","volume":"97","author":"G Opelz","year":"2014","unstructured":"Opelz G, Dohler B (2014) Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers. Transplantation 97(3):310\u2013315. https:\/\/doi.org\/10.1097\/01.tp.0000437672.78716.28","journal-title":"Transplantation"},{"issue":"2","key":"549_CR57","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/01.asn.0000043141.67989.39","volume":"14","author":"C Rigatto","year":"2003","unstructured":"Rigatto C (2003) Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 14(2):462\u2013468. https:\/\/doi.org\/10.1097\/01.asn.0000043141.67989.39","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"549_CR58","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000435838","volume":"5","author":"L Lullo Di","year":"2015","unstructured":"Di Lullo L, Gorini A, Russo D et al (2015) Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med 5(4):254\u2013266. https:\/\/doi.org\/10.1159\/000435838","journal-title":"Cardiorenal Med"},{"issue":"2S Suppl 1","key":"549_CR59","doi-asserted-by":"publisher","first-page":"S41S43","DOI":"10.1097\/TP.0000000000001691","volume":"102","author":"E Paoletti","year":"2018","unstructured":"Paoletti E (2018) mTOR inhibition and cardiovascular diseases: cardiac hypertrophy. Transplantation 102(2S Suppl 1):S41\u2013S43. https:\/\/doi.org\/10.1097\/TP.0000000000001691","journal-title":"Transplantation"},{"issue":"1","key":"549_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1\u201339 e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"issue":"7","key":"549_CR61","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/ndt\/gfv354","volume":"31","author":"E Paoletti","year":"2016","unstructured":"Paoletti E, Bellino D, Signori A et al (2016) Regression of asymptomatic cardiomyopathy and clinical outcome of renal transplant recipients: a long-term prospective cohort study. Nephrol Dial Transpl 31(7):1168\u20131174. https:\/\/doi.org\/10.1093\/ndt\/gfv354","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"549_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00007890-200107150-00021","volume":"72","author":"K Midtvedt","year":"2001","unstructured":"Midtvedt K, Ihlen H, Hartmann A et al (2001) Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study. Transplantation 72(1):107\u2013111","journal-title":"Transplantation"},{"issue":"10","key":"549_CR63","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1432-2277.2012.01513.x","volume":"25","author":"J Malyszko","year":"2012","unstructured":"Malyszko J, Oberbauer R, Watschinger B (2012) Anemia and erythrocytosis in patients after kidney transplantation. Transpl Int 25(10):1013\u20131023. https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01513.x","journal-title":"Transpl Int"},{"issue":"2","key":"549_CR64","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-6143.2009.02949.x","volume":"10","author":"AK Israni","year":"2010","unstructured":"Israni AK, Snyder JJ, Skeans MA et al (2010) Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transpl 10(2):338\u2013353. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02949.x","journal-title":"Am J Transpl"},{"issue":"4","key":"549_CR65","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s40620-017-0411-0","volume":"30","author":"K Schulte","year":"2017","unstructured":"Schulte K, Vollmer C, Klasen V et al (2017) Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism. J Nephrol 30(4):607\u2013615. https:\/\/doi.org\/10.1007\/s40620-017-0411-0","journal-title":"J Nephrol"},{"key":"549_CR66","doi-asserted-by":"publisher","first-page":"Cd010699","DOI":"10.1002\/14651858.CD010699.pub2","volume":"11","author":"P Masson","year":"2014","unstructured":"Masson P, Henderson L, Chapman JR et al (2014) Belatacept for kidney transplant recipients. Cochrane Database Syst Rev 11:Cd010699. https:\/\/doi.org\/10.1002\/14651858.CD010699.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"7659","key":"549_CR67","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","volume":"336","author":"J Hippisley-Cox","year":"2008","unstructured":"Hippisley-Cox J, Coupland C, Vinogradova Y et al (2008) Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 336(7659):1475\u20131482. https:\/\/doi.org\/10.1136\/bmj.39609.449676.25","journal-title":"BMJ"},{"issue":"12","key":"549_CR68","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/ctr.12466","volume":"28","author":"M Benguzzi","year":"2014","unstructured":"Benguzzi M, Mansell H, Hassan A et al (2014) Contribution of impaired renal function to cardiovascular risk prediction models in renal transplant recipients. Clin Transpl 28(12):1383\u20131392. https:\/\/doi.org\/10.1111\/ctr.12466","journal-title":"Clin Transpl"},{"issue":"1","key":"549_CR69","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1523-1755.2004.00751.x","volume":"66","author":"D Ducloux","year":"2004","unstructured":"Ducloux D, Kazory A, Chalopin JM (2004) Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int 66(1):441\u2013447. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00751.x","journal-title":"Kidney Int"},{"issue":"2","key":"549_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/TP.0b013e31821f303f","volume":"92","author":"SA Silver","year":"2011","unstructured":"Silver SA, Huang M, Nash MM, Prasad GV (2011) Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients. Transplantation 92(2):183\u2013189. https:\/\/doi.org\/10.1097\/TP.0b013e31821f303f","journal-title":"Transplantation"},{"key":"549_CR71","doi-asserted-by":"publisher","first-page":"750579","DOI":"10.1155\/2014\/750579","volume":"2014","author":"H Mansell","year":"2014","unstructured":"Mansell H, Stewart SA, Shoker A (2014) Validity of cardiovascular risk prediction models in kidney transplant recipients. ScientificWorldJournal 2014:750579. https:\/\/doi.org\/10.1155\/2014\/750579","journal-title":"ScientificWorldJournal"},{"issue":"1","key":"549_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/TP.0b013e3182516cdc","volume":"94","author":"I Soveri","year":"2012","unstructured":"Soveri I, Holme I, Holdaas H et al (2012) A cardiovascular risk calculator for renal transplant recipients. Transplantation 94(1):57\u201362. https:\/\/doi.org\/10.1097\/TP.0b013e3182516cdc","journal-title":"Transplantation"},{"issue":"1","key":"549_CR73","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/TP.0b013e31827722c9","volume":"95","author":"I Soveri","year":"2013","unstructured":"Soveri I, Snyder J, Holdaas H et al (2013) The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials. Transplantation 95(1):142\u2013147. https:\/\/doi.org\/10.1097\/TP.0b013e31827722c9","journal-title":"Transplantation"},{"issue":"22","key":"549_CR74","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.109.901413","volume":"121","author":"S Blankenberg","year":"2010","unstructured":"Blankenberg S, Zeller T, Saarela O et al (2010) Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 121(22):2388\u20132397. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.901413","journal-title":"Circulation"},{"issue":"4","key":"549_CR75","doi-asserted-by":"publisher","first-page":"301","DOI":"10.6061\/clinics\/2015(04)14","volume":"70","author":"WJ Li","year":"2015","unstructured":"Li WJ, Chen XM, Nie XY et al (2015) Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis. Clinics 70(4):301\u2013311. https:\/\/doi.org\/10.6061\/clinics\/2015(04)14","journal-title":"Clinics"},{"issue":"11","key":"549_CR76","doi-asserted-by":"publisher","first-page":"e79302","DOI":"10.1371\/journal.pone.0079302","volume":"8","author":"YJ Cheng","year":"2013","unstructured":"Cheng YJ, Yao FJ, Liu LJ et al (2013) B-type natriuretic peptide and prognosis of end-stage renal disease: a meta-analysis. PLoS One 8(11):e79302. https:\/\/doi.org\/10.1371\/journal.pone.0079302","journal-title":"PLoS One"},{"issue":"2","key":"549_CR77","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5301\/jn.5000169","volume":"26","author":"W Zhang","year":"2013","unstructured":"Zhang W, He J, Zhang F et al (2013) Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J Nephrol 26(2):243\u2013253. https:\/\/doi.org\/10.5301\/jn.5000169","journal-title":"J Nephrol"},{"issue":"3","key":"549_CR78","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/ndt\/gfm738","volume":"23","author":"GM Connolly","year":"2008","unstructured":"Connolly GM, Cunningham R, McNamee PT et al (2008) Troponin T is an independent predictor of mortality in renal transplant recipients. Nephrol Dial Transpl 23(3):1019\u20131025. https:\/\/doi.org\/10.1093\/ndt\/gfm738","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"549_CR79","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1600-6143.2012.04317.x","volume":"13","author":"MT Keddis","year":"2013","unstructured":"Keddis MT, El-Zoghby ZM, El Ters M et al (2013) Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survival. Am J Transpl 13(2):406\u2013414. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04317.x","journal-title":"Am J Transpl"},{"issue":"7","key":"549_CR80","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2215\/CJN.00930209","volume":"4","author":"S Abedini","year":"2009","unstructured":"Abedini S, Holme I, Marz W et al (2009) Inflammation in renal transplantation. Clin J Am Soc Nephrol 4(7):1246\u20131254. https:\/\/doi.org\/10.2215\/CJN.00930209","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"549_CR81","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ckj\/sfx120","volume":"11","author":"E Melilli","year":"2018","unstructured":"Melilli E, Manonelles A, Montero N et al (2018) Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same? Clin Kidney J 11(3):413\u2013421. https:\/\/doi.org\/10.1093\/ckj\/sfx120","journal-title":"Clin Kidney J"},{"issue":"5","key":"549_CR82","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000362492","volume":"39","author":"G Cianciolo","year":"2014","unstructured":"Cianciolo G, Capelli I, Angelini ML et al (2014) Importance of vascular calcification in kidney transplant recipients. Am J Nephrol 39(5):418\u2013426. https:\/\/doi.org\/10.1159\/000362492","journal-title":"Am J Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0549-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-0549-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0549-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:07Z","timestamp":1777564567000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/3\/389\/8328152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0549-4","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This article does not contain any studies with human participants performed by any of the authors; therefore, informed consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}